Open AccessBook
Martindale : the extra pharmacopoeia
TLDR
Part 1 Monographs on drugs and ancillary substances, Supplementary drugs and other substances, and Indexes - directory of manufacturers.About:
The article was published on 1993-01-01 and is currently open access. It has received 1788 citations till now. The article focuses on the topics: Pharmacopoeia.read more
Citations
More filters
Journal ArticleDOI
Occurrence, fate and effects of pharmaceutical substances in the environment- A review
Bent Halling-Sørensen,S. Nors Nielsen,P.F. Lanzky,Flemming Ingerslev,Hans-Christian Holten Lützhøft,S.E. Jørgensen +5 more
TL;DR: Present knowledge does not reveal if regular therapeutic use may be the source of a substance carried by sewage effluent into the aquatic system, even though clofibrate, a lipid lowering agent, has been identified in ground and tap water samples from Berlin.
Journal ArticleDOI
Antibacterial Activity and Mechanism of Action of the Silver Ion in Staphylococcus aureus and Escherichia coli
TL;DR: The results of the present study suggest that silver ions may cause S. aureus and E. coli bacteria to reach an ABNC state and eventually die.
Journal ArticleDOI
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
TL;DR: Vancomycin is a glycopeptide antibiotic that is one of the most widely used antibiotics in the United States for the treatment of serious gram-positive streptococcus aureus infections.
Journal ArticleDOI
Bioactive compounds in seaweed: functional food applications and legislation
Susan Løvstad Holdt,Stefan Kraan +1 more
TL;DR: Worldwide research on bioactive compounds in seaweed is reviewed, mainly of nine genera or species of seaweed, which are also available in European temperate Atlantic waters, i.e. Laminaria sp.
Journal ArticleDOI
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease
TL;DR: The results from the cohort studies, international comparisons, and clinical trials are remarkably consistent and estimate that a long term reduction in serum cholesterol concentration of 0.6 mmol/l (10%), which can be achieved by moderate dietary change,owers the risk of ischaemic heart disease by 50%" at age 40, falling to 20% at age 70.